title: [Where is the diagnosis of anthrax?].
abstract: The large use of antibiotics entailed a dizzy fall of the bacteriological positivity in diagnosis of acute anthrax, from 98-100% to 25% in average. Common serological methods are of low sensitivity and not so confluent. The more sophisticated methods (ELISA, EITB) are of a much better sensitivity but their employment in field epidemiological investigations is difficult and does not be suitable for a retrospective diagnosis. These inconveniences can be successfully surmounted by use of the anthraxin skin test. This test allows to diagnose acute anthrax in 98-100% of cases, and retrospectively (from 45 days to 30 years after recovery) in an average of 86.2% of cases. This skin test is simple for use, and does not requires a special medical competence.
authors.affiliation: Centre Médical Chaïm Sheba, Unité des Maladies Infectieuses, Université de Tel-Aviv, Tel-Hashomer, Israël.
authors.forename: E N
authors.initials: EN
authors.lastname: Shlyakhov
authors.forename: E
authors.initials: E
authors.lastname: Rubinstein
mesh_terms: D000881:Anthrax / Q000175:diagnosis* / Q000382:microbiology; D001408:Bacillus anthracis / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D012698:Serologic Tests; D012882:Skin Tests
vernacular_title: Où en est le diagnostic du charbon?